Karen Sims
CIK: 0001984652
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABUS
Arbutus Biopharma Corp
Officer
Discretionary Trading P&L
Holdings
About Sims Karen
Sims Karen (SEC CIK 0001984652) files insider reports with the SEC as Chief Medical Officer of Arbutus Biopharma Corp (ABUS).
Signal8 holds 2 ownership filings by Sims Karen, all Form 4s, filed between Feb 5, 2025 and Feb 19, 2025. Those filings report 2 transactions, from Feb 4, 2025 to Feb 14, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Sims Karen's filings is in WARMINSTER, PA.
Recent filings by Sims Karen
Other insiders filing for Arbutus Biopharma Corp (ABUS)
- Beardsley Robert A, Director
- Nguyen Tuan, Chief Financial Officer
- Sawhney Roger, Director
- Androski Lindsay, President and CEO
- Hasija Anuj, Director
- Bishop Joseph E, Director